AI assistant
Sending…
Werewolf Therapeutics, Inc. — Director's Dealing 2021
Jun 15, 2021
34192_dirs_2021-06-15_62638668-84cd-4419-8abc-a4ec31c9edf1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Werewolf Therapeutics, Inc. (HOWL)
CIK: 0001785530
Period of Report: 2021-06-14
Reporting Person: Karunatilake Chulani (Chief Technology Officer)
More from Werewolf Therapeutics, Inc.
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 13
Major Shareholding Notification
2026
Feb 11
Regulatory Filings
2026
Feb 6
Director's Dealing
2026
Jan 20
Major Shareholding Notification
2026
Jan 16
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 12